Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
Kuros Biosciences AG (“Kuros” or the “Company”), a leader in next generation bone graft technologies, notes the completi…